Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

Published:2018-05-04 Issue: Volume:24 Page:2767-2776
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Qi Qi¹,Niu Jinghui²,Chen Tao¹,Yin Hongshan¹,Wang Tao¹,Jiang Zhian¹

Affiliation:

1. Department of Cardiology, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland)

2. Department of Orthopedics, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of intracoronary administration of small doses of nicorandil and verapamil on blood pressure and heart rate;American Heart Journal Plus: Cardiology Research and Practice;2024-10

2. Intracoronary Injection of Nicorandil Alleviates No-Reflow in Elderly Patients with Acute STEMI Undergoing Emergency PCI;International Journal of Pharmacology;2024-08-01

3. Long-term outcome and prognostic value of angiographic slow/no-reflow phenomenon after emergency percutaneous coronary intervention for ST-elevation myocardial infarction;Coronary Artery Disease;2024-04-02

4. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review;Journal of Cardiovascular Pharmacology;2023-08

5. EFFICACY AND SAFETY OF NICORANDIL IN ACUTE CORONARY SYNDROME: A META-ANALYSIS;2023-04-06